Publicaciones en las que colabora con Jesús J. Sola (27)

2017

  1. Mid-term oncologic outcome of a novel approach for locally advanced colon cancer with neoadjuvant chemotherapy and surgery

    Clinical and Translational Oncology, Vol. 19, Núm. 3, pp. 379-385

  2. Perineural Invasion is a Major Prognostic and Predictive Factor of Response to Adjuvant Chemotherapy in Stage I–II Colon Cancer

    Annals of Surgical Oncology, Vol. 24, Núm. 4, pp. 1077-1084

2016

  1. Clinical significance of cellular and acellular mucin pools in rectal carcinoma following preoperative chemoradiotherapy

    Clinical and Translational Oncology, Vol. 18, Núm. 7, pp. 714-721

2015

  1. Impact of Perineural and Lymphovascular Invasion on Oncological Outcomes in Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy and Surgery

    Annals of Surgical Oncology, Vol. 22, Núm. 3, pp. 916-923

  2. Long-term oncologic results in cancer of the rectum treated by preoperative chemoradiotherapy and surgery: An analysis of 500 cases

    Revista Espanola de Enfermedades Digestivas, Vol. 107, Núm. 6, pp. 340-346

2014

  1. Tumor response assessment in locally advanced colon cancer after neoadjuvant chemotherapy

    Journal of Gastrointestinal Oncology, Vol. 5, Núm. 2, pp. 104-111

2013

  1. Long-term follow-up study of gastroduodenal lesions after radioembolization of hepatic tumors

    World Journal of Gastroenterology, Vol. 19, Núm. 19, pp. 2935-2940

  2. Prognosis factors for recurrence in patients with locally advanced rectal cancer preoperatively treated with chemoradiotherapy and adjuvant chemotherapy

    Diseases of the Colon and Rectum, Vol. 56, Núm. 4, pp. 416-421

  3. Surgical training on rectal cancer surgery: Do supervised senior residents differ from consultants in outcomes?

    International Journal of Colorectal Disease, Vol. 28, Núm. 5, pp. 671-677

2012

  1. Cáncer gástrico hereditario difuso: Estrategias para disminuir el riesgo tumoral

    Revista Espanola de Enfermedades Digestivas

  2. Fc gamma receptor polymorphisms as predictive markers of Cetuximab efficacy in epidermal growth factor receptor downstream-mutated metastatic colorectal cancer

    European Journal of Cancer, Vol. 48, Núm. 12, pp. 1774-1780

  3. Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: A validation phase II trial

    International Journal of Radiation Oncology Biology Physics, Vol. 83, Núm. 2, pp. 587-593

  4. Tumor fibroso solitario maligno gigante de hígado que expresa IGF II

    Cirugia Espanola

2011

  1. Accuracy of endoscopic ultrasound to assess tumor response after neoadjuvant treatment in rectal cancer: Can we trust the findings?

    Diseases of the Colon and Rectum, Vol. 54, Núm. 9, pp. 1141-1146

  2. MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells

    Stem Cells, Vol. 29, Núm. 11, pp. 1661-1671

  3. Morbidity, mortality, and pathological response in patients with gastric cancer preoperatively treated with chemotherapy or chemoradiotherapy

    Journal of Surgical Oncology, Vol. 104, Núm. 2, pp. 124-129

  4. Patterns of response after preoperative treatment in gastric cancer

    International Journal of Radiation Oncology Biology Physics, Vol. 80, Núm. 3, pp. 698-704

  5. Transthoracic oesophagectomy with lymphadenectomy in 100 oesophageal cancer patients. Multidisciplinary approach

    Clinical and Translational Oncology, Vol. 13, Núm. 12, pp. 899-903

2009

  1. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells

    Clinical Cancer Research, Vol. 15, Núm. 7, pp. 2281-2290

2008

  1. Liver disease induced by radioembolization of liver tumors: Description and possible risk factors

    Cancer, Vol. 112, Núm. 7, pp. 1538-1546